| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/02/2009 | WO2009041734A1 Agonistic antibody against human thrombopoietin receptor |
| 04/02/2009 | WO2009041733A1 Receptor mutant, and method for detection of factor associated with lifestyle-related disease using the same |
| 04/02/2009 | WO2009041643A1 Method of modifying isoelectric point of antibody via amino acid substitution in cdr |
| 04/02/2009 | WO2009041633A1 Method of labeling membrane protein with the use of coiled coil |
| 04/02/2009 | WO2009041621A1 Anti-il-6 receptor antibody |
| 04/02/2009 | WO2009041613A1 Modified antibody constant region |
| 04/02/2009 | WO2009041501A1 Factor involved in latent infection with herpesvirus, and use thereof |
| 04/02/2009 | WO2009041470A1 Method for producing hydroxylated adamantane using cytochrome p450 |
| 04/02/2009 | WO2009041415A1 Novel glucose dehydrogenase |
| 04/02/2009 | WO2009041409A1 Modified creatinine amidohydrolase |
| 04/02/2009 | WO2009041113A1 NK CELL HAVING Fc RECEPTOR GENE INTRODUCED THEREIN, METHOD FOR PRODUCTION OF THE SAME, AND METHOD FOR ASSAY ON ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY USING THE SAME |
| 04/02/2009 | WO2009041062A1 Anti-glypican-3 antibody having improved kinetics in plasma |
| 04/02/2009 | WO2009040819A2 DOWN-REGULATION OF MORTALIN BY siRNA |
| 04/02/2009 | WO2009040674A2 A public and immunogenic cd4+ t cell epitope of the hiv tat protein and its applications |
| 04/02/2009 | WO2009040665A2 Plants having increased biomass |
| 04/02/2009 | WO2009040555A2 A method for generating a recombinant clonal cell line and novel reagents for use in the method |
| 04/02/2009 | WO2009040529A1 Bacterial vaccine |
| 04/02/2009 | WO2009040444A1 Rna isolation method |
| 04/02/2009 | WO2009040431A1 Permanent inactivation of nucleases |
| 04/02/2009 | WO2009040338A1 Designed armadillo repeat proteins |
| 04/02/2009 | WO2009040131A1 Vv promoter-driven overexpression of recombinant antigens |
| 04/02/2009 | WO2009040113A2 C5a BINDING NUCLEIC ACIDS |
| 04/02/2009 | WO2009040092A2 Pna conjugates targeted to the emu enhancer of the igh locus as therapeutic agent for bcl-2 translocation driven follicular cell lymphoma clonal expansion |
| 04/02/2009 | WO2009039822A1 Gel carrier for performing the comet assay having an automation option in a robot-supported analysis operation for implementing a high-throughput method |
| 04/02/2009 | WO2009039743A1 Sirnas useful for inhibiting expression of tyrosinase gene, the compositions comprising the sirnas and their uses |
| 04/02/2009 | WO2009039704A1 A method for producing human kallikrein 1 |
| 04/02/2009 | WO2009039657A1 High concentration chitosan-nucleic acid polyplex compositions |
| 04/02/2009 | WO2009039630A1 Optimized nucleic acid sequences for the expression of vb4-845 |
| 04/02/2009 | WO2009039628A1 Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo |
| 04/02/2009 | WO2009039601A1 3.4 kb mitochondrial dna deletion for use in the detection of cancer |
| 04/02/2009 | WO2009022845A3 Promoter for the high level expression in plant-tissue culture and vector using the same |
| 04/02/2009 | WO2009021971A3 Novel targets and compounds for therapeutic intervention of hiv infection |
| 04/02/2009 | WO2009019458A3 Erythropoietin fusion proteins |
| 04/02/2009 | WO2009019441A3 Granulocyte colony stimulating factor |
| 04/02/2009 | WO2009018250A3 Use of rpa4 and rpa4/rpa32 hybrid polypeptides for modulating cell proliferation |
| 04/02/2009 | WO2009016249A3 Transgenic plants with increased stress tolerance and yield |
| 04/02/2009 | WO2009013611A3 Modified esterase and its applications |
| 04/02/2009 | WO2009013160A3 Butanol production in a eukaryotic cell |
| 04/02/2009 | WO2009012467A3 Increasing grain yield through targeted reduction in ethylene signaling |
| 04/02/2009 | WO2009009906A8 Isoflavonoid production in plants |
| 04/02/2009 | WO2009007855A3 Reversible sirna-based silencing of mutant and endogenous wild-type huntingtin gene and its application for the treatment of huntington's disease |
| 04/02/2009 | WO2009007714A3 Human pancreatic polypeptide (hpp) analogues and their effects on feeding behaviour |
| 04/02/2009 | WO2009006990A3 Minor splicosome assay system for modulating cell division |
| 04/02/2009 | WO2009005809A3 Compositions and methods for treating and diagnosing cancer |
| 04/02/2009 | WO2009003671A3 Hyperactive variants of the transposase protein of the transposon system sleeping beauty |
| 04/02/2009 | WO2008156702A3 Bacteria mediated gene silencing |
| 04/02/2009 | WO2008150150A3 Suppression of resistance in insects to bacillus thuringiensis cry toxins, using toxins that do not require the cadherin receptor |
| 04/02/2009 | WO2008133938A3 Targeted integration into the ppp1r12c locus |
| 04/02/2009 | WO2008127486A3 Replication-proficient dsrna capsids and uses thereof |
| 04/02/2009 | WO2008122794A3 Breast cancer methods, medicaments and agents |
| 04/02/2009 | WO2008112004A3 ANTIBODIES DIRECTED TO αVβ6 AND USES THEREOF |
| 04/02/2009 | WO2008109558A4 Nucleic acid compounds for inhibiting tlr gene expression and uses thereof |
| 04/02/2009 | WO2008109495A4 Nucleic acid compounds for inhibiting cd40 gene expression and uses thereof |
| 04/02/2009 | WO2008094860A3 Treating ocular diseases using peroxisome proliferator-activated receptor delta antagonists |
| 04/02/2009 | WO2008070144A3 Imprinted genes and disease |
| 04/02/2009 | WO2008064443A3 Genes associated to sucrose content |
| 04/02/2009 | WO2008054881A3 Antibacterial and plasmid elimination agents |
| 04/02/2009 | WO2008027337A3 Compositions for reducing cell adhesion to bubbles |
| 04/02/2009 | WO2007146511A8 Compounds and methods for modulating gene expression |
| 04/02/2009 | WO2007045063A3 Polynucleotides, dna constructs and methods for the alteration of plant cellulose content |
| 04/02/2009 | WO2006052807A3 A dna molecule of mortierella alpina lpaat homolog |
| 04/02/2009 | WO2006034300A3 Great wall kinases and uses thereof |
| 04/02/2009 | WO2006023495A3 Carotenoid hydroxylase enzymes |
| 04/02/2009 | WO2005123913A3 Reversibly modified thermostable enzyme compositions and methods of making and using the same |
| 04/02/2009 | WO2005121323A3 Methods for ex vivo propagation of somatic hair follicle stem cells |
| 04/02/2009 | WO2005118797A3 Biosynthetic gene cluster for tautomycetin |
| 04/02/2009 | WO2005096805A3 Cambium/xylem-preferred promoters and uses thereof |
| 04/02/2009 | WO2005086900A3 Phospholipases, nucleic acids encoding them and methods for making and using them |
| 04/02/2009 | WO2005067632A3 Lipid compositions and use thereof |
| 04/02/2009 | WO2005062854A3 Polyamides for nucleic acid delivery |
| 04/02/2009 | WO2005059094A3 Novel methods of inorganic compound discovery and synthesis |
| 04/02/2009 | WO2005047477A3 Interspersed repetitive element rnas as substrates, inhibitors and delivery vehicles for rnai |
| 04/02/2009 | WO2005044991A3 Compositions and methods of use for a fibroblast growth factor |
| 04/02/2009 | WO2005044974A3 Cell death-related nucleases and their uses |
| 04/02/2009 | WO2005033292A3 Methods of establishing intercellular communication in an endothelial cell layer and uses thereof |
| 04/02/2009 | WO2005033291A3 Hormone response element binding transregulators |
| 04/02/2009 | WO2005030926A3 Variants of glycoside hydrolases |
| 04/02/2009 | WO2005029944A3 Refined plant transformation |
| 04/02/2009 | WO2005023986A3 Microrna as ligands and target molecules |
| 04/02/2009 | WO2003087125A3 A novel g protein-coupled purinergic receptor, gave 17 |
| 04/02/2009 | US20090089900 Parthenocarpic tomatoes and production method thereof |
| 04/02/2009 | US20090089899 Method for Enhancing Drought Stress Tolerance in Plants by Active AREB1 |
| 04/02/2009 | US20090089898 Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby |
| 04/02/2009 | US20090089897 Seed-Preferred Promoters |
| 04/02/2009 | US20090089896 Plant metabolite exporter gene promoters |
| 04/02/2009 | US20090089895 Antifungal polypeptides |
| 04/02/2009 | US20090089894 Metacaspase II in engineering soybean for disease resistance |
| 04/02/2009 | US20090089893 Sucrose synthase 3 promoter from rice and uses thereof |
| 04/02/2009 | US20090089892 Generation of plants with improved pathogen resistance |
| 04/02/2009 | US20090089891 Transcription factor stress-related proteins and methods of use in plants |
| 04/02/2009 | US20090089890 Methods and means for removal of a selected dna sequence |
| 04/02/2009 | US20090089889 Neuromedin u receptor subtype 1 deficient transgenic mice and uses thereof |
| 04/02/2009 | US20090088563 Consisting of a sense and antisense region that form a duplex region; and from zero to one overhang regions; gene silencing, gene expression inhibition; gene therapy, drug discovery; cancer, Alzheimer's disease, diabetes |
| 04/02/2009 | US20090088562 Oligonucleotide analogs having cationic intersubunit linkages |
| 04/02/2009 | US20090088559 Method for preparing modified polypeptides |
| 04/02/2009 | US20090088558 Tumor necrosis factor specific antibody hybrid for use in treatment and prevention of autoimmune, rheumatoid arthritic, graft rejection and graft-versus-host disorder |
| 04/02/2009 | US20090088557 Novel semaphorin genes (i) |
| 04/02/2009 | US20090088555 44 Human Secreted Proteins |
| 04/02/2009 | US20090088398 Recombinant adenoviral vectors and methods of use |
| 04/02/2009 | US20090088382 Use of the cathelicidin LL-37 and derivatives therof for wound healing |